Home›Legal›CJC-1295 in Florida
CJC-1295 in Florida: Legal Status & Provider Guide (2026)
Quick Answer
CJC-1295 is a prescription substance in the United States. CJC-1295 is a synthetic GHRH analog with no FDA approval and no bulk compounding authorization. Federal compliance for compounding facilities is uncertain. Clinical use occurs in a regulatory gray area. In Florida, compounding is governed by the Florida Board of Pharmacy (FBP). In Florida, advanced practice registered nurses (APRNs) with prescriptive authority and physician assistants may prescribe compounded peptides within the scope of their collaborative agreement. Florida's telehealth laws permit prescribing without prior in-person visit in many contexts, which has made Florida a hub for telehealth peptide programs. Prescribers must hold a Florida license to prescribe to Florida patients.
Federal Legal Status
FDA Approval Status
Not FDA-approved. Not on the FDA 503A or 503B bulk substances lists. CJC-1295 (with or without DAC) is an unapproved research peptide.
Compounding Pharmacy Rules (Federal)
CJC-1295 is not on the FDA bulk substances list for 503A or 503B compounding. FDA has issued guidance indicating that unapproved peptides like CJC-1295 may not be lawfully compounded by facilities subject to FDA oversight. Providers offering it operate in a legally uncertain space under federal law.
Also Known As
Modified GRF (1–29) · Mod GRF 1–29 · DAC:GRF
Primary Research Areas
- Growth hormone release
- Anti-aging
- Body composition
- Muscle recovery
Florida Pharmacy Board & Compounding Rules
Regulator
Compounding Overview
Florida has a large and active compounding pharmacy sector. The Florida Board of Pharmacy (Department of Health) regulates sterile and non-sterile compounding, requiring separate permits for each type. Florida pharmacies that compound sterile preparations must comply with USP 797 and undergo periodic inspections. Florida has specific rules for "office use" compounding — a provision that allows prescribers to order pre-mixed sterile compounds for use in their offices, which is relevant to many peptide clinics.
Notable Rules
- Florida requires separate permits for sterile and non-sterile compounding.
- Florida allows "office use" compounding with specific restrictions — relevant to many peptide clinical practices.
- USP 797 compliance is mandatory for all sterile compounding facilities.
- Florida telehealth laws are permissive by national standards, making the state a major market for telehealth peptide programs.
- Out-of-state pharmacies must be registered with the Florida Board of Pharmacy to ship into the state.
Prescribing Requirements in Florida
In Florida, advanced practice registered nurses (APRNs) with prescriptive authority and physician assistants may prescribe compounded peptides within the scope of their collaborative agreement. Florida's telehealth laws permit prescribing without prior in-person visit in many contexts, which has made Florida a hub for telehealth peptide programs. Prescribers must hold a Florida license to prescribe to Florida patients.
About CJC-1295
CJC-1295 is a synthetic analog of GHRH designed for extended half-life through Drug Affinity Complex (DAC) technology. The DAC version binds to albumin in the bloodstream, extending its half-life significantly compared to sermorelin. It is often studied in combination with ipamorelin.
For more research information, mechanism of action, and provider availability, see the CJC-1295 research profile on PeptideBase.
Frequently Asked Questions
- What is the difference between CJC-1295 with DAC and without DAC?
- CJC-1295 with DAC binds to albumin and has a half-life of approximately 1–2 weeks, allowing less frequent dosing. CJC-1295 without DAC (also called Modified GRF 1-29) has a much shorter half-life of approximately 30 minutes, similar to sermorelin, and requires more frequent administration.
CJC-1295 Providers in Florida
No providers currently listed in Florida for CJC-1295. Browse the full directory to find providers offering CJC-1295.
Browse all CJC-1295 providers →CJC-1295 Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare CJC-1295 legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .